KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Acadia Pharmaceuticals (ACAD) Long-Term Debt Repayments: 2009-2012

Historic Long-Term Debt Repayments for Acadia Pharmaceuticals (ACAD) over the last 4 years, with Dec 2012 value amounting to $4,000.

  • Acadia Pharmaceuticals' Long-Term Debt Repayments fell 55.56% to $4,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $32,000, marking a year-over-year decrease of 58.97%. This contributed to the annual value of $32,000 for FY2012, which is 58.97% down from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Long-Term Debt Repayments of $4,000 as of Q4 2012, which was down 55.56% from $9,000 recorded in Q3 2012.
  • Acadia Pharmaceuticals' Long-Term Debt Repayments' 5-year high stood at $1.4 million during Q4 2009, with a 5-year trough of -$221,000 in Q2 2009.
  • Moreover, its 3-year median value for Long-Term Debt Repayments was $11,000 (2011), whereas its average is $38,583.
  • Examining YoY changes over the last 5 years, Acadia Pharmaceuticals' Long-Term Debt Repayments showed a top increase of 261.99% in 2010 and a maximum decrease of 96.96% in 2010.
  • Over the past 4 years, Acadia Pharmaceuticals' Long-Term Debt Repayments (Quarterly) stood at $1.4 million in 2009, then tumbled by 96.96% to $42,000 in 2010, then plummeted by 78.57% to $9,000 in 2011, then tumbled by 55.56% to $4,000 in 2012.
  • Its Long-Term Debt Repayments stands at $4,000 for Q4 2012, versus $9,000 for Q3 2012 and $10,000 for Q2 2012.